Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT

Abstract

A 32-year-old man with CML in second chronic phase developed primary graft failure following matched unrelated donor transplantation using cryopreserved marrow cells. He was successfully regrafted within 60 days from a second fully matched donor using a non-myeloablative conditioning regimen, with minimal toxicity. He remains in complete haematological, cytogenetic and molecular remission 2 years after second transplant. We believe that reduced intensity or ‘mini-transplants’ may be preferable for patients requiring second allografts which are usually associated with a high transplant-related mortality. Bone Marrow Transplantation (2001) 27, 547–549.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Kernan NG, Bartsch G, Ash R et al. Retrospective analysis of 462 unrelated marrow transplants facilitated by the National Marrow Donor Program for the treatment of acquired and congenital disorders of the lymphohematopoietic system and congenital metabolic disorders New Engl J Med 1993 328: 593–602

    Article  CAS  PubMed  Google Scholar 

  2. Ash R, Casper J, Chitambar C et al. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors New Engl J Med 1990 322: 485–494

    Article  CAS  PubMed  Google Scholar 

  3. McGlave P, Shu Z, Wen W et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years’ experience of the National Marrow Donor Program Blood 2000 95: 2219–2226

    CAS  PubMed  Google Scholar 

  4. Beatty P, Clift R, Mickelson E et al. Marrow transplantation from related donors other than HLA-identical siblings New Engl J Med 1985 313: 765–771

    Article  CAS  PubMed  Google Scholar 

  5. Gingrich R, Howe C, Goeken N et al. Successful bone marrow transplantation with partially matched unrelated donors Transplant Proc 1985 17: 450–452

    Google Scholar 

  6. Storb R, Prentice R, Thomas E et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anemia Br J Haematol 1983 55: 573–585

    Article  CAS  PubMed  Google Scholar 

  7. Martin P, Hansen J, Buckner C et al. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts Blood 1985 66: 664–672

    CAS  PubMed  Google Scholar 

  8. Grandage V, Cornish J, Pamphilon D et al. Second allogeneic bone marrow transplants from unrelated donors for graft failure following initial unrelated donor bone marrow transplantation Bone Marrow Transplant 1998 21: 687–690

    Article  CAS  PubMed  Google Scholar 

  9. Mrsic M, Horowitz M, Atkinson K et al. Second HLA-identical sibling transplants for leukemic recurrence Bone Marrow Transplant 1992 9: 269–275

    CAS  PubMed  Google Scholar 

  10. Estey E, Thall P, Andreeff M et al. Use of granulocyte colony stimulating factor before, during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony stimulating factor J Clin Oncol 1994 12: 671–678

    Article  CAS  PubMed  Google Scholar 

  11. Byrne J, Stainer C, Cull G et al. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor transplantation for leukaemia Bone Marrow Transplant 2000 25: 411–417

    Article  CAS  PubMed  Google Scholar 

  12. Stockschlader M, Kruger W, Kroschke G et al. Use of cryopreserved bone marrow in allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 569–572

    CAS  PubMed  Google Scholar 

  13. Mehta J, Powles R, Singhal S et al. Outcome of autologous rescue after failed engraftment of allogeneic marrow Bone Marrow Transplant 1996 17: 213–217

    CAS  PubMed  Google Scholar 

  14. Remberger M, Ringden O, Ljungman P et al. Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation Bone Marrow Transplant 1998 22: 73–78

    Article  CAS  PubMed  Google Scholar 

  15. Pawson R, Macdonald I, Potter M et al. Fludarabine based conditioning (‘mini-transplant’) for second allograft in acute leukaemia Br J Haematol 1999 105: (Suppl. 1) 132a

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Byrne, J., Musuka, C., Davy, B. et al. Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT. Bone Marrow Transplant 27, 547–549 (2001). https://doi.org/10.1038/sj.bmt.1702825

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702825

Keywords

Search

Quick links